This suggests that it may not carry the same risks associated with exogenous GH therapy, which include joint stiffness, radiculopathy, and the risk of edema
This does not mean every elevated SAH result proves toxicity. It means toxic and inflammatory burden should be considered when methylation support fails, symptoms worsen with methyl donors, glutathione demand is high, or the patient has mold, chemical, gastrointestinal, renal or mitochondrial clues
[10] Growth hormone also has well-documented effects on insulin resistance, which could compound the glycaemic effects of retatrutide
Large meals overwhelm a stomach that is already emptying slowly
Research published in Photochemistry and Photobiology found that doses above 0.6mg daily in type III subjects increased melanin optical density by less than 5% compared to 0.5mg daily, while nausea incidence rose from 18% to 34%
Several studies suggest that similar to lipids, reductions in food intake via intestinal protein in rodents are due to CCK release and subsequent activation of VANs, as (1) intestinal protein infusion increases CCK in rodents and humans 188,189